South Street Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
South Street Advisors's NVO Position: Q4 2025 in Review
South Street Advisors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 24,537 shares — an estimated $1.36M sold.
South Street Advisors first reported a position in NVO in Q1 2022 and held it in 15 quarters. The position peaked at $33M in Q2 2024. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- South Street Advisors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- South Street Advisors sold 24,537 Novo Nordisk shares in Q4 2025, an estimated $1.36M.
- South Street Advisors first reported a position in Novo Nordisk in Q1 2022 and held it in 15 quarters.
- South Street Advisors's Novo Nordisk position peaked at $33M in Q2 2024.
- 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on South Street Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.